Veradermics, INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NYSE
John W Childs, a Director of Veradermics, Inc, sold 100,000 shares of common stock on August 12, 2026.
NYSE
Veradermics, Inc. secures a $30 million investment from Suvretta Capital through a private placement of pre-funded warrants.
NYSE
Veradermics Director John W. Childs filed an amended Form 4 to correct the nature of indirect beneficial ownership for 294,117 common shares.
NYSE
Suvretta Capital Management and affiliated funds significantly increased their beneficial ownership in Veradermics, Inc. through open market purchases in early February 2026.